Nitroxoline
-
Nitroxoline
structure -
-
CAS No:
4008-48-4
-
Formula:
C9H6N2O3
-
Chemical Name:
Nitroxoline
-
Synonyms:
8-Quinolinol,5-nitro-;5-Nitro-8-quinolinol;8-Hydroxy-5-nitroquinoline;5-Nitro-8-hydroxyquinoline;Nitroxoline;Nibiol;Nitroxolin;5-Nitro-8-oxyquinoline;5-Nitro-8-oxychinoline;5NOK;Noxibiol;5-Nitroxine;BAS 58;5-Nitrox;A 82;NSC 74947;NSC 74948;5-(Hydroxyl[oxido]amino)-8-hydroxyquinoline;52440-95-6;64667-01-2
- Categories:
-
CAS No:
Description
Nitroxoline is an antibiotic that has proven to be very effective at combating biofilm infections. Nitroxoline functions by chelating Fe2+ and Zn2+ ions from the biofilm matrix.
Solid
Nitroxoline is a monohydroxyquinoline in which the hydroxy group is positioned at C-8 with a nitro group trans to it at C-5. It has a role as an antimicrobial agent, an antifungal agent, a renal agent and an antiinfective agent. It is a C-nitro compound and a monohydroxyquinoline.|Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. It is a hydroxyquinoline derivative unrelated to other classes of drugs. Nitroxoline is active against bacterial gyrases.
Nitroxoline Basic Attributes
190.16
190.16
223-662-4
A8M33244M6
760393|74947
DTXSID4046284
J - Antiinfectives for systemic use
2933499090
Characteristics
78.9
2.1
Solid
1.5±0.1 g/cm3
180 °C
419°C at 760 mmHg
207.2±25.9 °C
1.728
alcohol: very slightly soluble
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
0mmHg at 25°C
LD50 oral in rat: 510mg/kg
Safety Information
Ⅲ
6.1
UN 2811 6.1/PG 3
3
23/24/25-36/37/38-22/24/25-20/21/22
26-36-45
VC8225000
T,Xi,Xn
Toxic/Irritant
Stable under normal temperatures and pressures.
P261-P280-P301 + P310-P305 + P351 + P338-P311
H301 + H311 + H331-H315-H319-H335
|Danger|H301+H311+H331 (65.96%): Toxic if swallowed, in contact with skin or if inhaled [Danger Acute toxicity, oral; acute toxicity, dermal; acute toxicity, inhalation]|P261, P264, P270, P271, P280, P301+P310, P302+P352, P304+P340, P305+P351+P338, P311, P312, P321, P322, P330, P332+P313, P337+P313, P361, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 141 companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Drug Information
Nitroxoline is an antibiotic agent.
Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. (See all compounds classified as Anti-Infective Agents, Urinary.)|Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)
This drug may also have antitumor activity by inhibition of type 2 methionine aminopeptidase (MetAP2) protein which is involved in angiogenesis. Its antibacterial activity may stem from the metal ion complexation vital for bacterial growth.
5-nitro-8-hydroxyquinoline
Nitroxoline Use and Manufacturing
The oxidation of 8-hydroxy-5-nitrosoquinoline (10) to 8-hydroxy-5-nitroquinoline(11 ) was carried out according to the procedure ofPetrow and Sturgeon20. Finely grounded 8-hydroxy-5-nitrosoquinoline hydrochloride (10) (15.0 g, 0.7mmol) was added into a 500 mL beaker containingconcentrated nitric acid (45 mL) and water (30 mL)in an ice bath. The mixture was stirred for 85 min at17 °C. Equal volume of cold water was added andthe mixture cooled to 0 °C and alkaline was madewith cold concentrated potassium hydroxidesolution pH 13.0. The red potassium salt wasdecomposed on neutralization with acetic acid, filtered by suction and washed with water. Theresidue was recrystallized from ethanol to afford abright yellow crystal of 8-hydroxy-5-nitroquinoline.Yield 14.10 g (90.1percent), mp 179 °C (lit 179.5-181.5°C)20.
5-Nitro-8-hydroxyquinoline is an antimicrobial agent used for the treatment of urinary tract infection. 5-Nitro-8-hydroxyquinoline is also a potent and reversible inhibitor of cathepsin B. 5-Nitro-8-hydroxyquinoline has been shown to have anti-cancer activity.
Computed Properties
Molecular Weight:190.16
XLogP3:2.1
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:4
Exact Mass:190.03784206
Monoisotopic Mass:190.03784206
Topological Polar Surface Area:78.9
Heavy Atom Count:14
Complexity:229
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Nitroxoline
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives -
CN
3 YRS
Business licensedTrader Supplier of chemical -
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of Flavors & Fragrances,Catalyst & Auxiliary,Intermediates,Dyes & Pigments,Inorganic Chemistry,petro chemicals,Surfactant,Food Additives,Water Treatment Chemicals -
CN
1 YR
Business licensedTrader Supplier of Thiamphenicol,Furazidine,Spinosad,Nitroxoline,Alverine citrate
Learn More Other Chemicals
-
(2E)-3-(1-METHYL-1H-PYRROL-2-YL)ACRYLIC ACID
51485-76-8
-
Benadryl N-oxide hydrochloride
13168-00-8
-
6-CHLORO-3-IODO-IMIDAZO[1,2-A]PYRIDINE
885275-59-2
-
(2-Bromophenyl)diphenylphosphine Formula
62336-24-7
-
1-Morpholinocyclopentene Formula
936-52-7
-
4-[2-(Boc-amino)ethoxy]-benzoic acid Formula
168892-66-8
-
3-amino-5-bromopyridine-2-carboxylic acid Structure
870997-85-6
-
2-Amino-6-methylpyridine Structure
1824-81-3
-
What is 3-Bromo-2-methylthiophene
30319-05-2
-
What is THIOPHEN-2-YLMETHYL-PHOSPHONICACIDDIETHYLESTER
2026-42-8